Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$51 Mln
P/E Ratio
--
P/B Ratio
0.41
Industry P/E
--
Debt to Equity
0.04
ROE
-0.54 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-34.92
CFO
$-248.71 Mln
EBITDA
$-275.51 Mln
Net Profit
$-322.98 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Singular Genomics Systems Inc (OMIC)
| 2.99 | 1.57 | -7.70 | 26.09 | -54.69 | -- | -- |
|
BSE Sensex*
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
|
|---|---|---|---|
|
Singular Genomics Systems Inc (OMIC)
| 40.40 | -77.11 | -82.61 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 36.19 | 10,117.70 | 20.54 | 23.13 | |
| 296.28 | 8,962.72 | 23.48 | 58.42 | |
| 24.72 | 9,739.03 | -- | -28.77 | |
| 101.38 | 9,903.71 | 30.43 | 14.16 |
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4,... consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private. Address: 3010 Science Park Road, San Diego, CA, United States, 92121 Read more
Founder, CEO, President & Chairperson of the Board
Mr. Andrew Spaventa
Founder, CEO, President & Chairperson of the Board
Mr. Andrew Spaventa
Headquarters
San Diego, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Singular Genomics Systems Inc (OMIC) stood at $ 204 Mln as on 30-Sep-24
The share price of Singular Genomics Systems Inc (OMIC) is $20.01 (NASDAQ) as of 21-Feb-2025 09:30 EDT. Singular Genomics Systems Inc (OMIC) has given a return of -54.69% in the last 3 years.
Singular Genomics Systems Inc (OMIC) has a market capitalisation of $ 51 Mln as on 21-Feb-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Singular Genomics Systems Inc (OMIC) is 0.41 times as on 21-Feb-2025, a 82% discount to its peers’ median range of 2.30 times.
Since, TTM earnings of Singular Genomics Systems Inc (OMIC) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Singular Genomics Systems Inc (OMIC) and enter the required number of quantities and click on buy to purchase the shares of Singular Genomics Systems Inc (OMIC).
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private. Address: 3010 Science Park Road, San Diego, CA, United States, 92121
The CEO & director of Mr. Andrew Spaventa. is Singular Genomics Systems Inc (OMIC), and CFO & Sr. VP is Mr. Andrew Spaventa.
There is no promoter pledging in Singular Genomics Systems Inc (OMIC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,031
|
|
|
989
|
|
|
950
|
|
|
915
|
| Singular Genomics Systems Inc (OMIC) | Ratios |
|---|---|
|
Return on equity(%)
|
-61.67
|
|
Operating margin(%)
|
-3195.01
|
|
Net Margin(%)
|
-3237.88
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Singular Genomics Systems Inc (OMIC) was $0 Mln.
